Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools

Summary Abstract Cardiovascular diseases, principally ischaemic heart disease and stroke, are the leading causes of global mortality and morbidity. Together with other non-communicable diseases, they account for more than 60% of global deaths and pose major social, economic and developmental challenges worldwide. In Africa, there is now compelling evidence that the major cardiovascular disease (CVD) risk factors are on the rise, and so are the related fatal and non-fatal sequelae, which occur at significantly younger ages than seen in high-income countries. In order to tackle this rising burden of CVD, the H3Africa Cardiovascular Working Group will hold an inaugural workshop on 30 May 2014 in Cape Town, South Africa. The primary workshop objectives are to enhance our understanding of the genetic underpinnings of the common major CVDs in Africa and strengthen collaborations among the H3Africa teams and other researchers using novel genomic and epidemiological tools to contribute to reducing the burden of CVD on the continent.

[1]  V. Feigin,et al.  Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.

[2]  G. Mensah.  Introduction: Progress in cardiovascular diseases and diabetes in Africa. , 2013, Progress in cardiovascular diseases.

[3]  G. Mensah.  Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. , 2013, Progress in cardiovascular diseases.

[4]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[5]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[6]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[7]  Anthony S. Kim,et al.  Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease , 2011, Circulation.

[8]  M. Owolabi.  Taming the burgeoning stroke epidemic in Africa: stroke quadrangle to the rescue. , 2011, The West Indian medical journal.

[9]  S. Tollman,et al.  The burden of non-communicable diseases in South Africa , 2009, The Lancet.

[10]  N. Futrakul,et al.  Microalbuminuria—A Biomarker of Renal Microvascular Disease , 2009, Renal failure.

[11]  S. Clark,et al.  Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study , 2008, The Lancet.

[12]  B. Ovbiagele.  Microalbuminuria: Risk factor and potential therapeutic target for stroke? , 2008, Journal of the Neurological Sciences.

[13]  G. Mensah.  Epidemiology of stroke and high blood pressure in Africa , 2008, Heart.

[14]  Peter Libby,et al.  Inflammatory mechanisms: the molecular basis of inflammation and disease. , 2007, Nutrition reviews.

[15]  G. Mensah.  Endothelial Biomedicine: Endothelial Biomedicine: The Public Health Challenges and Opportunities , 2007 .

[16]  R. Henning,et al.  Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage , 2006, Journal of Cardiovascular Pharmacology.

[17]  T. Macdonald.  Preventing Chronic Diseases: A Vital Investment , 2006 .

[18]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[19]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[20]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[21]  Baumgartner-Parzer Sm,et al.  The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. , 2001 .

[22]  W. Waldhäusl,et al.  The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[23]  E. Frohlich.  Mechanisms contributing to high blood pressure. , 1983, Annals of internal medicine.